...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Gasoline
5
Jan 23, 2017 07:19PM
3
Jan 30, 2017 12:57PM
2
Jan 30, 2017 01:31PM
3
Jan 30, 2017 02:31PM
1
Jan 30, 2017 07:44PM

Jan 30, 2017 07:57PM
2
Jan 30, 2017 08:34PM
4
Jan 30, 2017 09:29PM

Jan 30, 2017 10:46PM
5
Jan 31, 2017 10:52AM
4
Jan 31, 2017 03:03PM
4
Feb 03, 2017 09:32PM
3
Feb 04, 2017 03:04PM
3
Feb 05, 2017 01:11PM
2
Feb 05, 2017 06:56PM

At the AGM the longest dosed patient on ZEN3964 was just over 4 months. If we are still going it speaks volumes for our potential.

tada

3
Feb 09, 2017 12:30PM
3
Feb 09, 2017 02:15PM
Share
New Message
Please login to post a reply